European equities traded in the US as American depositary receipts were trending slightly lower late Friday morning, declining 0.12% to 1,815.75 on the S&P Europe Select ADR Index, which is up 0.68% for the week.

From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and furniture maker Natuzzi (NTZ), which advanced 3.1% and 2.8% respectively. They were followed by pharmaceutical company Sanofi (SNY) and software firm SAP (SAP), which were up 2% and 1.8% respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company Cellectis (CLLS), which fell 4.3% and 2.8% respectively. They were followed by biotech firm Evaxion (EVAX) and internet advertising company Criteo (CRTO), which were down 2.5% and 2.3% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics (AKTX) and medical device maker Smith & Nephew (SNN), which rose 5.1% and 1.8% respectively. They were followed by alcoholic beverage company Diageo (DEO) and lender Lloyds Banking Group (LYG), which increased 1.6% and 1.5% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firmTrinity Biotech (TRIB), which dropped 5.4% and 4.1% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Amarin (AMRN), which lost 4% and 3.4% respectively.